Author | Ajjai Shivaram Alva, MBBS | OncLive

Author | Ajjai Shivaram Alva, MBBS

Articles

Dr. Alva on the Shift Toward Combination Therapy in mRCC

February 15, 2020

Video

Ajjai Shivaram Alva, MBBS, discusses the shift toward combination therapy versus monotherapy in metastatic renal cell carcinoma.

Dr. Alva on Results of the CABOSUN Trial in RCC

February 04, 2020

Video

Ajjai Shivaram Alva, MBBS, discusses the results of the CABOSUN trial in renal cell carcinoma.

Dr. Alva on TKI Monotherapy and Combinations for RCC

January 22, 2020

Video

Ajjai Shivaram Alva, MBBS, discusses TKI monotherapy and in combination with immunotherapy for patients with renal cell carcinoma.

Dr. Alva on the Toxicity Profiles of TKIs in RCC

January 06, 2020

Video

Ajjai Shivaram Alva, MBBS, discusses class-specific toxicities of TKIs in renal cell carcinoma.

x